161 related articles for article (PubMed ID: 33673431)
1. Molecular Docking Studies and Biological Evaluation of Berberine-Benzothiazole Derivatives as an Anti-Influenza Agent via Blocking of Neuraminidase.
Kumar M; Chung SM; Enkhtaivan G; Patel RV; Shin HS; Mistry BM
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673431
[TBL] [Abstract][Full Text] [Related]
2. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
[TBL] [Abstract][Full Text] [Related]
3. Berberine-piperazine conjugates as potent influenza neuraminidase blocker.
Enkhtaivan G; Kim DH; Park GS; Pandurangan M; Nicholas DA; Moon SH; Kadam AA; Patel RV; Shin HS; Mistry BM
Int J Biol Macromol; 2018 Nov; 119():1204-1210. PubMed ID: 30099043
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
5. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
McSharry JJ; McDonough AC; Olson BA; Drusano GL
Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
[TBL] [Abstract][Full Text] [Related]
7. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
[TBL] [Abstract][Full Text] [Related]
8. Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition.
Guo M; Ni J; Yu J; Jin J; Ma L; Zhang H; Wang D; Zhang X; Dou J; Zhou C
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842256
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
11. A novel influenza virus neuraminidase inhibitor AV5027.
Ivachtchenko AV; Ivanenkov YA; Mitkin OD; Yamanushkin PM; Bichko VV; Leneva IA; Borisova OV
Antiviral Res; 2013 Dec; 100(3):698-708. PubMed ID: 24416774
[TBL] [Abstract][Full Text] [Related]
12. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
[TBL] [Abstract][Full Text] [Related]
14. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
[TBL] [Abstract][Full Text] [Related]
15. In vitro anti-influenza viral activities of stilbenoids from the lianas of Gnetum pendulum.
Liu AL; Yang F; Zhu M; Zhou D; Lin M; Lee SM; Wang YT; Du GH
Planta Med; 2010 Nov; 76(16):1874-6. PubMed ID: 20539973
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (Relenze) in in vitro experiments].
L'vov DK; Burtseva EI; Galegov GA; Beliakova NV; Shevchenko ES; Kolobukhina LV; Merkulova LN; Prilipov AG; Leneva IA; Baranov NI; Gorelikov VN; Abramov DD
Vopr Virusol; 2010; 55(6):10-4. PubMed ID: 21381333
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro antiviral effects of berberine on influenza virus.
Wu Y; Li JQ; Kim YJ; Wu J; Wang Q; Hao Y
Chin J Integr Med; 2011 Jun; 17(6):444-52. PubMed ID: 21660679
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
19. Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence.
Gansukh E; Kazibwe Z; Pandurangan M; Judy G; Kim DH
Phytomedicine; 2016 Aug; 23(9):958-67. PubMed ID: 27387404
[TBL] [Abstract][Full Text] [Related]
20. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
